Delphi Management Partners VIII, L.L.C. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Delphi Management Partners VIII, L.L.C. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$13,170,000
-43.6%
2,263,0060.0%9.51%
-48.4%
Q2 2021$23,354,000
-1.9%
2,263,0060.0%18.44%
+12.2%
Q1 2021$23,806,000
-32.0%
2,263,0060.0%16.44%
-28.6%
Q4 2020$35,031,000
-19.2%
2,263,0060.0%23.03%
-32.7%
Q4 2019$43,381,0002,263,00634.24%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders